Common vitamin shows promise against silent liver disease
NCT ID NCT06843148
Summary
This study is testing whether a common vitamin, niacin (vitamin B3), can help reduce harmful fat buildup in the liver. Researchers will give 36 older adults with fatty liver disease either niacin or a placebo pill for 12-week periods to see if the vitamin helps the body store fat in safer places instead of the liver. The goal is to understand if this simple, low-dose treatment could help control a common liver condition linked to obesity and diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de recherche du CHUS
RECRUITINGSherbrooke, Quebec, J1H 5N4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.